1-8 of 8
Yngvar Fløisand, MD PhD
Close
Sort by
Journal Articles

A WT-1 and PRAME "Fast-DC" Immunotherapy As a Potential Post-Remission Strategy for AML

Yngvar Floisand, MD PhD, Iris Bigalke, MD, Dag Josefsen, MD PhD, Silke Raffegerst, PhD, Frauke Schnorfeil, PhD, Richard Addo, MD PhD, Dolores J. Schendel, PhD, Kai Pinkernell, MDMBA, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-139255
Published: 2020
Journal Articles

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Sunu Cyriac, MD MBBS, Auro Viswabandya, MD, Zeyad Al-Shaibani, MD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Wilson Lam, MD, Dennis Dong Hwan Kim, MD, Arjun Law, MDDM, Tobias Gedde-Dahl, MD PhD, Yngvar Floisand, MD PhD, Mats Remberger, PhD, Jonas Mattsson, MD, Fotios V. Michelis, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3341.
https://doi.org/10.1182/blood-2019-125941
Published: 2019
Journal Articles

DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment

Judith Eckl, PhD, Silke Raffegerst, PhD, Frauke Schnorfeil, PhD, Petra Prinz-Schulz, PhD, Christiane Fingerhut, Yngvar Floisand, MD PhD, Dag Josefsen, Iris Bigalke, MD, Kai Pinkernell, MDMBA, Gunnar Kvalheim, MD PhD, Dolores Schendel, Prof., Anna Tafuri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3923.
https://doi.org/10.1182/blood-2019-129749
Published: 2019
Journal Articles

A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De Novo Acute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy

Benedicte Sjo Tislevoll, MD, Oda Helen Eck Fagerholt, Nello Blaser, MS, PhD, Monica Hellesøy, MS, PhD, Stein-Erik Gullaksen, MS, PhD, Pilar Ayuda Duran, MS, PhD, Laure Isabelle Piechaczyk, MS, Dagim Tadele, MS, Jørn Skavland, MS, PhD, Sonia Gavasso, MS, PhD, Jorrit Enserink, MS, PhD, Yngvar Fløisand, MD PhD, Bjorn Gjertsen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1502.
https://doi.org/10.1182/blood-2018-99-116943
Published: 2018
Journal Articles

Immune Monitoring of Vaccine Quality and Persistence of Specific T Cell Responses in Five AML Patients Receiving Extended Dendritic Cell Vaccination Under Compassionate Use

Iris Bigalke, MD, Judith Eckl, PhD, Guri Solum, MSc, Kirsti Hønnåshagen, Msc, Lisbeth Skoge, MSc, Yngvar Fløisand, MD PhD, Dag Josefsen, MD PhD, Stein Sæbøe-Larssen, PhD, Christiane Geiger, PhD, Dolores Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2718.
https://doi.org/10.1182/blood-2018-99-114557
Published: 2018
Journal Articles

Poor Mobilizing Lymphoma Patients Rescued By Addition of Plerixafor during Stem Cell Mobilization Have Equal Survival As Good Mobilizers When Given High Dose Therapy with Autologous Stem Cell Support

Dag Josefsen, MD PhD, Yngvar Fløisand, MD PhD, Harald Holte, Jr., MD PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5826.
https://doi.org/10.1182/blood.V128.22.5826.5826
Published: 2016
Journal Articles

AML Patients in Minimal Residual Disease Vaccinated with a Novel Generation of Fast Dendritic Cells Expressing WT-1 and PRAME Mount Specific Immune Responses That Relate to Clinical Outcome

Iris Bigalke, Yngvar Fløisand, MD PhD, Guri Solum, Kirsti Hønnåshagen, Marianne Lundby, Kristina Anderson, MD PhD, Stein Sæbøe-Larssen, PhD, Else-Marit Inderberg, PhD, Judith Eckl, PhD, Dolores J Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3798.
https://doi.org/10.1182/blood.V126.23.3798.3798
Published: 2015
Journal Articles

Acute Myeloid Leukaemia Treatment in Adults in Norway Five Year Survival and Costs

Alette Glasø Skifjeld, Beate Bjørnstad, Yngvar Fløisand, MD PhD, Eline Aas, PhD
Journal: Blood
Blood (2015) 126 (23): 4490.
https://doi.org/10.1182/blood.V126.23.4490.4490
Published: 2015